MIT s recent investment in Marksans Pharma underscores the small-cap s hidden gem status, fuelled by its strong presence in stable OTC markets and strategic growth initiatives, signalling promising prospects for revenue and profit expansion.
Kolkata-based Suraksha Diagnostic eyes $100 million IPO; PE investor OrbiMed to sell stake moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Barring two companies – Balrampur Chini Mills and Shree Cement – rest of the stocks have given atleast double-digit returns so far in the current financial year.
Global healthcare-focussed mid-market private equity firm OrbiMed, which counts companies like Advanced Enzymes, Entero Healthcare, Marksans Pharma, Suraksha Clinic, Kapiva, Bharat Serum, and Asian Institute ..